NRXP Stock Analysis: Buy, Sell, or Hold?
NRXP - NRX Pharmaceuticals, Inc. Common Stock
$3.58
0.49 (15.86%)
▲
5d:
+13.65%
30d:
-12.9%
90d:
+16.99%
HOLD
MODERATE Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 17, 2026
8d
Get Alerted When NRXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NRXP shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NRXP shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
17.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRXP is currently trading at $3.58, which is considered slightly low relative to its 30-day fair value range of $3.37 to $4.30. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.2) compared to its historical average (10.0). Remarkably, the market is currently pricing in an annual earnings decline of 10.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $2.82, while resistance sits at $4.15. The stock is showing strong short-term momentum, up 15.9% recently.
Market Sentiment: NRXP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $42.00 (+1073.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $2.82, while resistance sits at $4.15. The stock is showing strong short-term momentum, up 15.9% recently.
Market Sentiment: NRXP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $42.00 (+1073.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.37 -
$4.30
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
Protect Your Profits
Holding NRXP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+15.9%)
- BULLISH: Trading 1073.2% below Wall St target ($42.00)
Trading Range Analysis
30-Day Trading Range
$3.37 -
$4.30
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.82
Resistance Level
$4.15
Current Trend
Strong Uptrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.16
Wall Street Target
$42.00
(+1073.2%)
Valuation Discount vs History
-10.4% cheaper
PE vs Historical
7.2 vs 10.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.4%
(market-implied from PE analysis)
1-Year Target
$3.22
(-10%)
2-Year Target
$2.90
(-19%)
3-Year Target
$2.61
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7→10)
$3.65
(+2%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.2 to 10.0
Stabilization Target:
$5.00
(+39.7%)
PE Expansion Potential:
+39.7%
Share & Embed Analysis
Last updated: August 08, 2026 5:25 AM ET
Data refreshes hourly during market hours. Next update: 6:25 AM
Data refreshes hourly during market hours. Next update: 6:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 55 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 52 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$36 | 56 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 57 HOLD |
Advanced NRXP Option Strategies
Professional options setups generated by AI based on today's NRXP price and gamma walls.
